Literature DB >> 9144768

Characterization of the allosteric binding pocket of human liver fructose-1,6-bisphosphatase by protein crystallography and inhibitor activity studies.

L F Iversen1, M Brzozowski, S Hastrup, R Hubbard, J S Kastrup, I K Larsen, L Naerum, L Nørskov-Lauridsen, P B Rasmussen, L Thim, F C Wiberg, K Lundgren.   

Abstract

The structures of three complexes of human fructose-1,6-bisphosphatase (FB) with the allosteric inhibitor AMP and two AMP analogues have been determined and all fully refined. The data used for structure determination were collected at cryogenic temperature (110 K), and with the use of synchrotron radiation. The structures reveal a common mode of binding for AMP and formycine monophosphate (FMP). 5-Amino-4-carboxamido-1 beta-D-5-phosphate-ribofuranosyl-1H-imidazole (AICAR-P) shows an unexpected mode of binding to FB, different from that of the other two ligands. The imidazole ring of AICAR-P is rotated 180 degrees compared to the AMP and FMP bases. This rotation results in a slightly different hydrogen bonding pattern and minor changes in the water structure in the binding pocket. Common features of binding are seen for the ribose and phosphate moieties of all three compounds. Although binding in a different mode, AICAR-P is still capable of making all the important interactions with the residues building the allosteric binding pocket. The IC50 values of AMP, FMP, and AICAR-P were determined to be 1.7, 1.4, and 20.9 microM, respectively. Thus, the approximately 10 times lower potency of AICAR-P is difficult to explain solely from the variations observed in the binding pocket. Only one water molecule in the allosteric binding pocket was found to be conserved in all four subunits in all three structures. This water molecule coordinates to a phosphate oxygen atom and the N7 atom of the AMP molecule, and to similarly situated atoms in the FMP and AICAR-P complexes. This implies an important role of the conserved water molecule in binding of the ligand.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144768      PMCID: PMC2143689          DOI: 10.1002/pro.5560060503

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  12 in total

1.  Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form).

Authors:  H M Ke; J Y Liang; Y P Zhang; W N Lipscomb
Journal:  Biochemistry       Date:  1991-05-07       Impact factor: 3.162

Review 2.  MOPAC: a semiempirical molecular orbital program.

Authors:  J J Stewart
Journal:  J Comput Aided Mol Des       Date:  1990-03       Impact factor: 3.686

3.  Contribution of gluconeogenesis to overall glucose output in diabetic and nondiabetic men.

Authors:  A Consoli; N Nurjhan
Journal:  Ann Med       Date:  1990-06       Impact factor: 4.709

4.  Activation of the fructose 1,6-bisphosphatase gene by 1,25-dihydroxyvitamin D3 during monocytic differentiation.

Authors:  D H Solomon; M C Raynal; G A Tejwani; Y E Cayre
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Toward a mechanism for the allosteric transition of pig kidney fructose-1,6-bisphosphatase.

Authors:  Y Zhang; J Y Liang; S Huang; W N Lipscomb
Journal:  J Mol Biol       Date:  1994-12-16       Impact factor: 5.469

6.  Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase.

Authors:  Y Zhang; J Y Liang; S Huang; H Ke; W N Lipscomb
Journal:  Biochemistry       Date:  1993-02-23       Impact factor: 3.162

7.  Isolation of a human liver fructose-1,6-bisphosphatase cDNA and expression of the protein in Escherichia coli. Role of ASP-118 and ASP-121 in catalysis.

Authors:  M R el-Maghrabi; M Gidh-Jain; L R Austin; S J Pilkis
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

8.  Allosteric transition of fructose-1,6-bisphosphatase.

Authors:  J Y Liang; Y Zhang; S Huang; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liver in vivo.

Authors:  E Van Schaftingen; L Hue; H G Hers
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

10.  Crystal structure of the neutral form of fructose 1,6-bisphosphatase complexed with regulatory inhibitor fructose 2,6-bisphosphate at 2.6-A resolution.

Authors:  J Y Liang; S Huang; Y Zhang; H Ke; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more
  1 in total

1.  Quadruple space-group ambiguity owing to rotational and translational noncrystallographic symmetry in human liver fructose-1,6-bisphosphatase.

Authors:  Armin Ruf; Tim Tetaz; Brigitte Schott; Catherine Joseph; Markus G Rudolph
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-10-28       Impact factor: 7.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.